These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
    Author: Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R.
    Journal: J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438.
    Abstract:
    Nausea and vomiting are difficult symptoms to manage in patients with advanced cancer. Several classes of antiemetics are available, including phenothiazines, butyrophenones, substituted benzamides and selective serotonin antagonists, as well as corticosteroids. Most patients will respond to either single agents or combinations that frequently include corticosteroids. A minority of patients will have nausea that fails to respond. The atypical antipsychotic, olanzapine, relieves nausea in some patients failing to respond to the usual antiemetics. Two case reports are presented and the rationale for olanzapine's benefit is discussed.
    [Abstract] [Full Text] [Related] [New Search]